Neuronally-directed effects of RXR activation in a mouse model of Alzheimer's disease. - Test2 - elhamkhani - TriplyDB

Neuronally-directed effects of RXR activation in a mouse model of Alzheimer's disease.

Neuronally-directed effects of RXR activation in a mouse model of Alzheimer's disease.

http://www.wikidata.org/entity/Q37644290

about

EFAD transgenic mice as a human APOE relevant preclinical model of Alzheimer's disease.Therapeutic potential of nuclear receptor agonists in Alzheimer's disease.Aβ Peptide Originated from Platelets Promises New Strategy in Anti-Alzheimer's Drug Development.Evidence that the Human Innate Immune Peptide LL-37 may be a Binding Partner of Amyloid-β and Inhibitor of Fibril Assembly.Steroid and Xenobiotic Receptor Signalling in Apoptosis and Autophagy of the Nervous System.Nuclear receptor agonist-driven modification of inflammation and amyloid pathology enhances and sustains cognitive improvements in a mouse model of Alzheimer's disease.Role of Microbes in the Development of Alzheimer's Disease: State of the Art - An International Symposium Presented at the 2017 IAGG Congress in San Francisco

P2860

Q38733357-B9CCDDC2-05B3-45EE-AF5C-3A60FC6FAACC Q39164346-8EF0576D-22B2-4979-97E1-ABEEE961CBA5 Q42002912-E1F23E08-AEE8-4308-95DF-A20B0294D9B3 Q42279346-3C4BAEEE-0E78-4CC0-AFA7-01060482BCFC Q47129713-0ECBE255-9001-4855-B064-570BB1526FAA Q49962878-DE600880-E777-4AE5-BD1E-D4BF66B5EFFA Q58754323-BD08DB56-7A69-4385-8F30-9E6A2BB18640

P2860

Neuronally-directed effects of RXR activation in a mouse model of Alzheimer's disease.

http://www.wikidata.org/entity/Q37644290

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 16 February 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Neuronally-directed effects of RXR activation in a mouse model of Alzheimer's disease.

@en

Neuronally-directed effects of RXR activation in a mouse model of Alzheimer's disease.

@nl

type

label

Neuronally-directed effects of RXR activation in a mouse model of Alzheimer's disease.

@en

Neuronally-directed effects of RXR activation in a mouse model of Alzheimer's disease.

@nl

prefLabel

Neuronally-directed effects of RXR activation in a mouse model of Alzheimer's disease.

@en

Neuronally-directed effects of RXR activation in a mouse model of Alzheimer's disease.

@nl

P1433

Q37644290-652739E9-126B-4747-9C00-02F2A918ED38

P1476

Q37644290-62A94790-FC78-46F7-982C-5E4101475F58

P2093

Q37644290-090C82ED-7E44-4CE8-BC12-D7F869DCCD96

Q37644290-27F19361-847D-4BB7-B77F-6B1D2EDC9763

Q37644290-2B191DD4-C895-402D-B143-014B38FEFD89

Q37644290-38A98887-94CC-4236-9FED-4BB22919E577

Q37644290-3C800D31-EE58-4BC9-8E20-2451B1B627D9

Q37644290-7640747C-C4C6-46E1-9BE6-C1878AD9A9A8

Q37644290-8EC9C5C1-128B-48F0-807F-21D223BB7BC8

P2860

Q37644290-001A300C-CB0D-45AF-9C6B-5F9269C1E9EB

Q37644290-018935A3-F2BD-4636-9223-45CB20AA5F62

Q37644290-05DF16C5-ED3E-43B0-BEFF-13D8ACABC8F0

Q37644290-0C025F04-9648-46A9-A169-67C46DA6B0DA

Q37644290-0C73D694-FFE9-479D-92B5-A93CD3D85607

Q37644290-15F24F02-CC19-43FE-87F4-AE2AF7836FBF

Q37644290-1B3CF36E-CFDE-4CBB-A9B7-FAD4C5F64A20

Q37644290-215F6059-FD1A-4D08-80A9-5EC27B16EB86

Q37644290-21E35BE2-4DB9-44C7-8676-74F7B447019A

Q37644290-225435B7-1670-4F4C-8862-9F13D1778953

P2888

Q37644290-BA3C74EA-6CE8-480E-98CF-FD7AF8940F1E

P304

Q37644290-2BA88D6C-0850-4E88-A8A9-EFDD28AD6178

P31

Q37644290-C0942963-AE2D-43D2-BEDF-5DA0EEA5157A

P356

Q37644290-72350B1F-B556-43C1-9068-D4D5035D16EB

P407

Q37644290-3D18D71E-CD34-4555-AAD5-1A86D2F1DC06

P478

Q37644290-5F62C39C-DE4F-4301-AEAA-E69984636F03

P50

Q37644290-0C7C22CE-700F-419E-B339-E41D74566DE7

P577

Q37644290-37141F3D-5078-4467-BD3D-D0417764E594

P698

Q37644290-F88DF560-DBBC-4AD6-8194-1B08E8704B64

P921

Q37644290-99B3F42D-00CD-478A-8A25-CFA2D8BA688B

P932

Q37644290-391AABEA-97CC-4D62-B438-71D1DA626543

P356

P1433

Scientific Reports

P1476

Neuronally-directed effects of RXR activation in a mouse model of Alzheimer's disease

@en

P2093

B Casali

http://www.w3.org/2001/XMLSchema#string

G E Landreth

http://www.w3.org/2001/XMLSchema#string

L Medarametla

http://www.w3.org/2001/XMLSchema#string

L Neilson

http://www.w3.org/2001/XMLSchema#string

M M Mariani

http://www.w3.org/2001/XMLSchema#string

R Lamb

http://www.w3.org/2001/XMLSchema#string

T R Jay

http://www.w3.org/2001/XMLSchema#string

P2860

Lysosomal sorting of amyloid-β by the SORLA receptor is impaired by a familial Alzheimer's disease mutation

ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models

Functions of lipoprotein receptors in neurons

Lysosomal proteolysis and autophagy require presenilin 1 and are disrupted by Alzheimer-related PS1 mutations

Comment on "ApoE-Directed Therapeutics Rapidly Clear -Amyloid and Reverse Deficits in AD Mouse Models"

Comment on "ApoE-Directed Therapeutics Rapidly Clear -Amyloid and Reverse Deficits in AD Mouse Models"

Mechanism of amyloid plaque formation suggests an intracellular basis of Abeta pathogenicity.

Low dose bexarotene treatment rescues dopamine neurons and restores behavioral function in models of Parkinson's disease.

Amyloid seeds formed by cellular uptake, concentration, and aggregation of the amyloid-beta peptide.

Loss of olfactory function in dementing disease.

P2888

P304

42270

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SREP42270

http://www.w3.org/2001/XMLSchema#string

P407

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-02-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28205585

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

5311933

http://www.w3.org/2001/XMLSchema#string